Sponsor:
Miltenyi Biomedicine GmbH
Code:
NCT06708845
Conditions
Lupus Nephritis
Systemic Lupus Erythematosus
Systemic Sclerosis (SSc)
Diffuse Cutaneous Systemic Sclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
zamtocabtagene autoleucel
Cyclophosphamide
Fludarabine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-28. This information was provided to ClinicalTrials.gov by Miltenyi Biomedicine GmbH on 2026-06-11.